Currently, CAR T-Cell Therapy has been approved for treating certain types of blood cancers, including acute lymphoblastic leukemia (ALL) and non-Hodgkin lymphoma. Ongoing research is exploring its effectiveness in other types of cancer, such as solid tumors.
